21 February 2016 - Merck CEO Kenneth Frazier talks about pricing, R&D—and why big pharmaceutical companies aren’t admired like they once were.

For more details, go to: http://www.wsj.com/articles/big-pharmas-delicate-dance-on-drug-prices-1456110323